AUROBINDO PHARMA LTD SCREENER.

IN

Narration Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17 Trailing Best Case Worst Case
Sales 2,426.12 3,037.98 3,523.87 4,381.48 4,627.40 5,855.32 8,099.79 12,120.52 13,794.65 14,909.54 16,499.84 18,272.35 16,669.47
Expenses 2,090.83 2,865.43 2,752.25 3,428.56 4,387.28 4,994.37 5,966.14 9,556.90 10,606.53 11,475.26 12,735.33 14,103.43 13,313.18
Operating Profit 335.29 172.55 771.62 952.92 240.12 860.95 2,133.65 2,563.62 3,188.12 3,434.28 3,764.51 4,168.92 3,356.29
Other Income 126.25 169.84 205.25 71.41 24.70 28.54 21.56 96.71 205.25 120.91 112.38 - -
Depreciation 100.37 127.60 149.34 171.50 200.53 248.74 312.53 332.61 392.37 427.63 557.97 557.97 557.97
Interest 69.42 93.22 73.09 64.65 277.24 266.64 310.16 159.87 256.70 66.72 77.72 77.72 77.72
Profit before tax 291.75 121.57 754.44 788.18 -212.95 374.11 1,532.52 2,167.85 2,744.30 3,060.84 3,241.20 3,533.23 2,720.60
Tax 53.60 21.36 191.36 225.12 -88.81 82.71 363.45 596.59 720.71 759.65 818.28 25% 25%
Net profit 238.48 100.26 563.40 563.45 -123.50 293.86 1,172.85 1,575.77 2,025.09 2,301.66 2,423.18 2,641.22 2,033.75
EPS 8.87 3.73 20.22 19.35 -4.24 10.09 40.24 53.97 34.61 39.29 41.36 45.08 34.71
Price to earning 3.51 5.69 4.66 5.06 -14.54 8.61 6.96 12.24 22.10 16.45 14.50 16.32 9.98
Price 31.10 21.23 94.28 98.03 61.69 86.88 280.01 660.68 764.67 646.23 599.70 735.78 346.35

RATIOS:
Dividend Payout 7.37% 24.14% 4.92% 10.42% 0.00% 14.86% 7.45% 8.33% 0.00% 0.00%
OPM 13.82% 5.68% 21.90% 21.75% 5.19% 14.70% 26.34% 21.15% 23.11% 23.03% 22.82%

TRENDS: 10 YEARS 7 YEARS 5 YEARS 3 YEARS RECENT BEST WORST

Sales Growth 22.35% 22.88% 26.36% 22.55% 10.67% 22.55% 10.67%
OPM 20.13% 20.97% 22.24% 22.50% 22.82% 22.82% 20.13%
Price to Earning 9.98 12.27 13.48 16.32 14.50 16.32 9.98
AUROBINDO PHARMA LTD SCREENER.IN

Narration Dec-15 Mar-16 Jun-16 Sep-16 Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18
Sales 3,505.60 3,745.92 3,766.59 3,775.45 3,906.18 3,641.63 3,678.75 4,435.89 4,336.11 4,049.09
Expenses 2,687.87 2,884.95 2,877.63 2,846.64 3,011.34 2,920.39 2,844.81 3,319.01 3,310.53 3,260.98
Operating Profit 817.73 860.97 888.96 928.81 894.84 721.24 833.94 1,116.88 1,025.58 788.11
Other Income 7.54 36.38 23.66 28.47 26.73 42.46 23.43 11.40 33.16 44.39
Depreciation 99.35 111.40 106.24 110.20 111.14 100.05 131.18 132.08 138.08 156.63
Interest 8.71 25.08 20.64 17.54 14.26 14.28 16.87 17.27 18.86 24.72
Profit before tax 717.21 760.87 785.74 829.54 796.17 649.37 709.32 978.93 901.80 651.15
Tax 174.22 206.36 200.84 223.99 217.67 117.15 190.99 197.96 306.94 122.39
Net profit 544.31 554.77 584.96 605.64 578.59 532.45 518.51 781.15 595.01 528.51

OPM 23% 23% 24% 25% 23% 20% 23% 25% 24% 19%
AUROBINDO PHARMA LTD SCREENER.IN

Narration Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17
Equity Share Capital 26.88 26.88 27.86 29.11 29.11 29.12 29.15 29.20 58.52 58.59
Reserves 1,097.14 1,214.38 1,801.22 2,415.72 2,310.54 2,576.64 3,721.00 5,126.71 7,228.78 9,313.32
Borrowings 1,908.40 2,332.97 2,154.56 2,414.25 3,095.94 3,435.46 3,769.14 4,451.07 5,041.07 3,364.14
Other Liabilities 621.66 652.24 807.67 1,013.20 802.04 1,374.51 1,989.09 3,336.05 3,612.92 3,845.31
Total 3,654.08 4,226.47 4,791.31 5,872.28 6,237.63 7,415.73 9,508.38 12,943.03 15,941.29 16,581.36

Net Block 1,236.75 1,398.77 1,710.85 1,738.60 2,194.65 2,638.87 2,721.67 3,705.64 4,179.69 4,833.78
Capital Work in Progress 278.13 536.30 570.08 657.42 645.41 218.51 309.72 419.63 848.14 1,458.08
Investments 60.42 0.26 0.28 38.53 38.54 22.28 19.79 19.79 122.96 245.87
Other Assets 2,078.78 2,291.14 2,510.10 3,437.73 3,359.03 4,536.07 6,457.20 8,797.97 10,790.50 10,043.63
Total 3,654.08 4,226.47 4,791.31 5,872.28 6,237.63 7,415.73 9,508.38 12,943.03 15,941.29 16,581.36

Working Capital 1,457.12 1,638.90 1,702.43 2,424.53 2,556.99 3,161.56 4,468.11 5,461.92 7,177.58 6,198.32
Debtors 665.01 889.76 956.01 1,230.98 1,239.96 1,596.98 2,636.57 3,539.17 4,606.68 2,765.33
Inventory 795.03 877.63 1,102.45 1,455.27 1,545.56 1,923.59 2,367.54 3,611.30 4,056.14 4,330.54

Debtor Days 100.05 106.90 99.02 102.55 97.81 99.55 118.81 106.58 121.89 67.70
Inventory Turnover 3.05 3.46 3.20 3.01 2.99 3.04 3.42 3.36 3.40 3.44

Return on Equity 21% 8% 31% 23% -5% 11% 31% 31% 28% 25%
Return on Capital Emp 7% 1% 13% 13% 3% 9% 20% 18% 18% 20%
AUROBINDO PHARMA LTD SCREENER.IN

Narration Mar-08 Mar-09 Mar-10 Mar-11 Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17
Cash from Operating Activity 195.17 102.57 426.84 335.11 326.25 274.87 646.28 1,236.81 1,419.76 -
Cash from Investing Activity -106.92 -406.28 -398.26 -603.10 -563.17 -245.87 -818.63 -1,016.94 -1,445.51 -
Cash from Financing Activity -217.47 164.99 -84.04 406.98 118.85 108.09 117.64 93.21 365.44 -
Net Cash Flow -129.22 -138.72 -55.46 138.99 -118.07 137.09 -54.71 313.08 339.69 -
How to use it?
You can customize this workbook as you want.
You can add custom formating, add conditional formating, add your own formulas… do ANYTHING.
Please don't edit the "Data Sheet" only.

After customization, you can upload this back on Screener.

Upload on: https://www.screener.in/excel/

Download your customized workbooks now onwards.

Now whenever you will "Export to excel" from Screener, it will export your customized file.

TESTING:
This is a testing feature currently.
You can report any formula errors on the worksheet at: screener.feedback@dalal-street.in
… do ANYTHING.

dalal-street.in
COMPANY NAME AUROBINDO PHARMA LTD
LATEST VERSION 2.10 PLEASE
CURRENT VERSION 2.10

META
Number of shares 58.59
Face Value 1
Current Price 599.7
Market Capitalization 35136.88

PROFIT & LOSS

Report Date Mar-08 Mar-09 Mar-10 Mar-11
Sales 2,426.12 3,037.98 3,523.87 4,381.48
Raw Material Cost 1,431.03 1,627.82 1,906.00 2,379.44
Change in Inventory 67.70 -8.92 184.92 206.42
Power and Fuel 152.17 182.72 194.91 208.26
Other Mfr. Exp 167.28 162.86 201.18 251.24
Employee Cost 190.10 243.67 327.28 425.07
Selling and admin 200.61 264.18 265.89 313.10
Other Expenses 17.34 375.26 41.91 57.87
Other Income 126.25 169.84 205.25 71.41
Depreciation 100.37 127.60 149.34 171.50
Interest 69.42 93.22 73.09 64.65
Profit before tax 291.75 121.57 754.44 788.18
Tax 53.60 21.36 191.36 225.12
Net profit 238.48 100.26 563.40 563.45
Dividend Amount 17.57 24.20 27.74 58.72

Quarters
Report Date Dec-15 Mar-16 Jun-16 Sep-16
Sales 3,505.60 3,745.92 3,766.59 3,775.45
Expenses 2,687.87 2,884.95 2,877.63 2,846.64
Other Income 7.54 36.38 23.66 28.47
Depreciation 99.35 111.40 106.24 110.20
Interest 8.71 25.08 20.64 17.54
Profit before tax 717.21 760.87 785.74 829.54
Tax 174.22 206.36 200.84 223.99
Net profit 544.31 554.77 584.96 605.64
Operating Profit 817.73 860.97 888.96 928.81

BALANCE SHEET
Report Date Mar-08 Mar-09 Mar-10 Mar-11
Equity Share Capital 26.88 26.88 27.86 29.11
Reserves 1097.14 1214.38 1801.22 2415.72
Borrowings 1908.4 2332.97 2154.56 2414.25
Other Liabilities 621.66 652.24 807.67 1013.2
Total 3,654.08 4,226.47 4,791.31 5,872.28
Net Block 1236.75 1398.77 1710.85 1738.6
Capital Work in Progress 278.13 536.3 570.08 657.42
Investments 60.42 0.26 0.28 38.53
Other Assets 2078.78 2291.14 2510.1 3437.73
Total 3,654.08 4,226.47 4,791.31 5,872.28
Receivables 665.01 889.76 956.01 1,230.98
Inventory 795.03 877.63 1102.45 1455.27
Cash & Bank 282.57 127.65 72.83 186.72
No. of Equity Shares 53765268 53765268 55728837 291121290
New Bonus Shares
Face value 5 5 5 1

CASH FLOW:
Report Date Mar-08 Mar-09 Mar-10 Mar-11
Cash from Operating Activity 195.17 102.57 426.84 335.11
Cash from Investing Activity -106.92 -406.28 -398.26 -603.10
Cash from Financing Activity -217.47 164.99 -84.04 406.98
Net Cash Flow -129.22 -138.72 -55.46 138.99

PRICE: 31.10 21.23 94.28 98.03

DERIVED:
Adjusted Equity Shares in Cr 26.88 26.88 27.86 29.11
 PLEASE DO NOT MAKE ANY CHANGES TO THIS SHEET

Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17

4,627.40 5,855.32 8,099.79 12,120.52 13,794.65 14,909.54
2,525.82 3,261.02 3,708.04 5,835.08 6,254.98 6,743.46
6.06 270.25 102.00 329.48 92.88 309.20
232.36 324.72 349.84 359.60 419.26 437.14
284.84 315.81 428.43 537.57 590.06 644.50
535.69 663.31 802.43 1,302.26 1,542.62 1,767.76
374.69 550.27 708.29 1,632.91 1,684.89 1,988.70
439.94 149.49 71.11 218.96 207.60 202.90
24.70 28.54 21.56 96.71 205.25 120.91
200.53 248.74 312.53 332.61 392.37 427.63
277.24 266.64 310.16 159.87 256.70 66.72
-212.95 374.11 1,532.52 2,167.85 2,744.30 3,060.84
-88.81 82.71 363.45 596.59 720.71 759.65
-123.50 293.86 1,172.85 1,575.77 2,025.09 2,301.66
29.11 43.68 87.41 131.28

Dec-16 Mar-17 Jun-17 Sep-17 Dec-17 Mar-18

3,906.18 3,641.63 3,678.75 4,435.89 4,336.11 4,049.09
3,011.34 2,920.39 2,844.81 3,319.01 3,310.53 3,260.98
26.73 42.46 23.43 11.40 33.16 44.39
111.14 100.05 131.18 132.08 138.08 156.63
14.26 14.28 16.87 17.27 18.86 24.72
796.17 649.37 709.32 978.93 901.80 651.15
217.67 117.15 190.99 197.96 306.94 122.39
 578.59 532.45 518.51 781.15 595.01 528.51
894.84 721.24 833.94 1116.88 1025.58 788.11

Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17

29.11 29.12 29.15 29.2 58.52 58.59
2310.54 2576.64 3721 5126.71 7228.78 9313.32
3095.94 3435.46 3769.14 4451.07 5041.07 3364.14
802.04 1374.51 1989.09 3336.05 3612.92 3845.31
6,237.63 7,415.73 9,508.38 12,943.03 15,941.29 16,581.36
2194.65 2638.87 2721.67 3705.64 4179.69 4833.78
645.41 218.51 309.72 419.63 848.14 1458.08
38.54 22.28 19.79 19.79 122.96 245.87
3359.03 4536.07 6457.2 8797.97 10790.5 10043.63
6,237.63 7,415.73 9,508.38 12,943.03 15,941.29 16,581.36
1,239.96 1,596.98 2,636.57 3,539.17 4,606.68 2,765.33
1545.56 1923.59 2367.54 3611.3 4056.14 4330.54
70.86 208.45 178.58 469.11 800.26 513.48
291121290 291211290 291457020 291982275 585169586 585882409

1 1 1 1 1 1

Mar-12 Mar-13 Mar-14 Mar-15 Mar-16 Mar-17

326.25 274.87 646.28 1,236.81 1,419.76
-563.17 -245.87 -818.63 -1,016.94 -1,445.51
118.85 108.09 117.64 93.21 365.44
-118.07 137.09 -54.71 313.08 339.69

61.69 86.88 280.01 660.68 764.67 646.23

29.11 29.12 29.15 29.20 58.52 58.59